$ cat ./records/gates-foundation-creates-the-gates-medical-research-institute-a-n-2018.txt
Gates Foundation Creates the Gates Medical Research Institute, a 'Nonprofit Biotech'
[RECORD.TXT] · cat --full
In 2018 the Gates Foundation launched the Bill & Melinda Gates Medical Research Institute (Gates MRI), an unusual 'nonprofit biotech' in Cambridge, Massachusetts, seeded with an initial grant of about $273 million. Its mission: develop drugs and vaccines for diseases of the world's poorest — tuberculosis, malaria, and diarrheal illness — that commercial drugmakers neglect because there is little profit in them. The institute runs early-stage research itself before partnering with industry to manufacture, and is behind work such as the MAM01 malaria antibody.
Free forever · No ads · Solo developer
If this was worth a read, help make the next entry possible.
Every entry in this archive was researched, verified, and written by one person — for free. No corporate funding. No ad revenue. Just a developer who believes verified history should be accessible to everyone. Your donation directly funds new entries.
Crypto accepted · No subscription required
← Previous
An 'Impatient Optimist,' Gates Champions Steven Pinker's Case That the World Is Improving
Next →
Gates Backs EarthNow, a Plan for Real-Time Video of the Whole Planet
[CROSS_REFERENCES] · grep --category='Global Health'
Related Accomplishments
January 2026
Gates-backed World Mosquito Program reaches 16 million people protected from dengue via Wolbachia method
The World Mosquito Program — backed in part by the Gates Foundation — announced in January 2026 that its Wolbachia-infected mosquito releases had reached over 16.1 million people across multiple countries, including Colombia, Indonesia, Brazil, Sri Lanka, Fiji, Vanuatu, and Vietnam. Wolbachia-carrying Aedes aegypti mosquitoes — which block dengue, Zika, chikungunya, and yellow fever transmission — had established self-sustaining populations in treated cities without requiring ongoing releases. Gold-standard randomised trials in Indonesia showed a 77% reduction in dengue incidence. The program represented one of the largest and most cost-effective vector control deployments in history.
2025
Gates-Funded Monoclonal Antibody Shows Early Promise as a Single-Shot Malaria Shield
[ARCHIVE_FUNDING] · INDEPENDENT · NO ADS
One developer. >300 verified entries. Zero ads. Forever free.
No sponsors, no paywall, no algorithm. If this archive has been useful to you, reader support is what keeps it running.